JAZZ - Jazz Pharmaceuticals plc

QQQ $ 461.48 $ 2.39 (0.52 %)

DIA $ 409.37 $ -0.57 (-0.14 %)

SPY $ 550.79 $ 0.74 (0.13 %)

TLT $ 98.70 $ 0.82 (0.84 %)

GLD $ 230.46 $ 0.64 (0.28 %)

Previous Close

$ 109.32

Open

$ 109.04

Bid

$ 105.53 x 158

Ask

$ 108.50 x 211

Day's Range

$ 106.56 - $ 109.32

52 Week Range

$ 99.06 - $ 143.32

Volume

1,619,975

Average Volume

Market Cap

6.75B

Beta (5Y Monthly)

$ 0.69

PE Ratio (TTM)

$ 17.09

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-01-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	02-28-2024	12-31-2023	10-K
4	11-08-2023	09-30-2023	10-Q
5	08-09-2023	06-30-2023	10-Q
6	05-10-2023	03-31-2023	10-Q
7	03-01-2023	12-31-2022	10-K
8	11-09-2022	09-30-2022	10-Q
9	08-03-2022	06-30-2022	10-Q
10	05-04-2022	03-31-2022	10-Q
11	03-01-2022	12-31-2021	10-K
12	11-09-2021	09-30-2021	10-Q
13	08-03-2021	06-30-2021	10-Q
14	05-04-2021	03-31-2021	10-Q
15	02-23-2021	12-31-2020	10-K
16	11-02-2020	09-30-2020	10-Q
17	08-04-2020	06-30-2020	10-Q
18	05-05-2020	03-31-2020	10-Q
19	02-25-2020	12-31-2019	10-K
20	11-05-2019	09-30-2019	10-Q
21	08-06-2019	06-30-2019	10-Q
22	05-07-2019	03-31-2019	10-Q
23	02-26-2019	12-31-2018	10-K
24	11-06-2018	09-30-2018	10-Q
25	08-07-2018	06-30-2018	10-Q
26	05-08-2018	03-31-2018	10-Q
27	02-27-2018	12-31-2017	10-K
28	11-07-2017	09-30-2017	10-Q
29	08-08-2017	06-30-2017	10-Q
30	05-09-2017	03-31-2017	10-Q
31	02-28-2017	12-31-2016	10-K
32	11-08-2016	09-30-2016	10-Q
33	08-09-2016	06-30-2016	10-Q
34	05-10-2016	03-31-2016	10-Q
35	02-23-2016	12-31-2015	10-K
36	11-09-2015	09-30-2015	10-Q
37	08-05-2015	06-30-2015	10-Q
38	05-07-2015	03-31-2015	10-Q
39	02-24-2015	12-31-2014	10-K
40	11-04-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Jazz Pharmaceuticals Launches $850M Senior...
09/04/2024 06:04:38

The notes will be general unsecured obligations of the Issuer and will accrue interest payable semiannually in arrears on March...

Jazz Intends To Offer $850M Of Exchangeabl...
09/03/2024 11:02:54

Jazz Pharmaceuticals, together with its consolidated subsidiaries, expects to use a portion of the net proceeds to prepay up to...

jazz-and-hikma-accused-of-delaying-sleep-disorder-generic-drug-to-maintain-high-prices

Jazz And Hikma Accused Of Delaying Sleep D...
08/28/2024 17:37:50

Jazz Pharmaceuticals and Hikma Pharmaceuticals will face trial over allegations of delaying a generic version of Xyrem, causing...

from-five-minutes-of-agony-its-now-just-seconds-says-brazilian-mother-celebrating-free-access-to-her-childs-life-saving-cbd-medicine

'From Five Minutes Of Agony, It's Now Just...
08/28/2024 01:11:55

the-only-fda-approved-cbd-treatment-for-severe-epilepsy-completes-key-phase-3-trial-in-japan-despite-missed-primary-goal

The Only FDA-Approved CBD Treatment For Se...
08/23/2024 13:15:58

Jazz Pharmaceuticals Provides Update On Ca...
08/22/2024 20:11:40

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced top-line results from the Phase 3 open-label, single-arm trial in Japan ...

A Closer Look at 12 Analyst Recommendation...
08/19/2024 14:00:54

JP Morgan Maintains Overweight on Jazz Pha...
08/19/2024 13:14:23

JP Morgan analyst Jessica Fye maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price target fro...

Decoding 11 Analyst Evaluations For Jazz P...
08/01/2024 17:03:43

Cantor Fitzgerald Reiterates Overweight on...
08/01/2024 16:52:13

Cantor Fitzgerald analyst Charles Duncan reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and maintains $140 ...

Piper Sandler Maintains Overweight on Jazz...
08/01/2024 15:58:39

Piper Sandler analyst David Amsellem maintains Jazz Pharmaceuticals (NASDAQ: JAZZ) with a Overweight and lowers the price ta...

RBC Capital Maintains Outperform on Jazz P...
08/01/2024 15:31:22

RBC Capital analyst Gregory Renza maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Outperform and lowers the price target...

Wells Fargo Maintains Equal-Weight on Jazz...
08/01/2024 13:42:07

Wells Fargo analyst Mohit Bansal maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Equal-Weight and lowers the price targe...

Needham Maintains Buy on Jazz Pharmaceutic...
08/01/2024 12:29:40

Needham analyst Ami Fadia maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and lowers the price target from $208 to $...

HC Wainwright & Co. Reiterates Buy on Jazz...
08/01/2024 12:18:10

HC Wainwright & Co. analyst Oren Livnat reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $200 pric...

Baird Maintains Outperform on Jazz Pharmac...
08/01/2024 11:55:14

Baird analyst Joel Beatty maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Outperform and lowers the price target from $1...

Jazz Pharmaceuticals Sees FY24 Adj EPS $19...
07/31/2024 20:26:14

Jazz Pharmaceuticals Q2 2024 Adj. EPS $5.3...
07/31/2024 20:08:00

Jazz Pharmaceuticals (NASDAQ:JAZZ) reported quarterly earnings of $5.30 per share which beat the analyst consensus estimate of ...

how-is-the-market-feeling-about-jazz-pharmaceuticals

How Is The Market Feeling About Jazz Pharm...
07/15/2024 19:00:27

Morgan Stanley Maintains Equal-Weight on J...
07/12/2024 17:07:29

Morgan Stanley analyst Jeffrey Hung maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Equal-Weight and lowers the price ta...